Beneficial impact of Ac3IV, an AVP analogue acting specifically at V1a and V1b receptors, on diabetes islet morphology and transdifferentiation of alpha- and beta-cells

Shruti Mohan, Ryan Lafferty, Neil Tanday, PR Flatt, Charlotte Moffett, Nigel Irwin

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)
23 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Beneficial impact of Ac3IV, an AVP analogue acting specifically at V1a and V1b receptors, on diabetes islet morphology and transdifferentiation of alpha- and beta-cells'. Together they form a unique fingerprint.

Medicine & Life Sciences